Medical/Pharmaceuticals

Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea

SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Yuyu Pharma has received recognition as a Great Place to Work from the mayor of Jechoen city. The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equality movement that focuses on th...

2019-07-17 21:00 669

AirXpanders® Announces Reduction in Force and Plan to Cease Operations

SAN JOSE, California, July 17, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the Company has reduced its workforce and plans to cease operations. ...

2019-07-17 07:17 3229

AirXpanders® Receives FDA 510(k) Clearance for a Smooth Shell Version of the AeroForm® Tissue Expander System

SAN JOSE, California, July 15, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k...

2019-07-15 09:17 813

Yuyu Pharma held the campaign for enhancing corporate transparency

SEOUL, South Korea, July 10, 2019 /PRNewswire/ -- Yuyu Pharma, a Korean pharmaceutical company celebrated its third year of implementing Yuyu's compliance management system by inviting senior management to its "Self-Compliance Day" workshop.

2019-07-11 16:43 1520

MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China

ROCKVILLE, Md. and SHANGHAI, July 10, 2019 /PRNewswire/ -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab Biopharma (I-Mab), aChina and U.S....

2019-07-11 04:01 1514

VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding

AUSTIN, Texas, July 10, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded additional non-dilutive funding in the form of a non-repayable cash grant totaling approximately$1.4 million from the Walloon Region, Belgium.  To date, Agen...

2019-07-10 20:30 8678

Spectrum Therapeutics partners with Canadian Mental Health Association's Not Myself Today® initiative

SMITHS FALLS, Ontario and TORONTO, July 10, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to announce a partnership with the Canadian Mental Health Association ("CMHA...

2019-07-10 20:00 7280

CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST

SUZHOU, China, July 9, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient has been dosed inChina with avapritinib in the ongoing global Phase III VOYAGER clinical trial. This study is designed to evaluate the safety and efficacy of avapritini...

2019-07-10 10:23 6641

Medeon Led and Completed Investments in Panther Orthopedics and Prodeon

TAIPEI, Taiwan, July 8, 2019 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), aTaiwan publicly traded medical device company, is pleased to announce that it recently led and closed two investments, in Panther Orthopedics and Prodeon. Panther Orthopedics is a Silicon Valley startup company pio...

2019-07-08 17:10 10011

New England Biolabs®, Inc. opens eighth subsidiary in Australia

IPSWICH, Massachusetts, July 4, 2019 /PRNewswire/ -- New England Biolabs (NEB® ), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd. Australia's Life Sciences industry is hom...

2019-07-03 22:00 1655

China SXT Pharmaceuticals, Inc. Announces TCM Homologous Supplements Production

TAIZHOU, China, July 3, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today announced ...

2019-07-03 20:00 13729

CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019

Novel real world evidence for AFSTYLA® and IDELVION® to be highlighted MELBOURNE, Australia, July 1, 2019 /PRNewswire/ -- Global biotherapeutics leaderCSL Behring announced today that the company will support the presentation of new data from its recombinant coagulation factor programs at this ...

2019-07-02 06:15 7163

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

KIRKLAND, Washington, July 1, 2019 /PRNewswire/ --  Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the Carillon Mitral Contour System® has been implanted in 1,0...

2019-07-01 19:10 988

WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies

SHANGHAI, June 29, 2019 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announces that it has been selected as one of MIT Technology Review's 50 Smartest Companies (TR50) for 2019. WuXi was chosen for its ded...

2019-06-29 13:26 8694

Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group

ARTARMON, Australia, June 28, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that it has secured$75 million in equity financing from Boston Scientific Corporation (NYSE: BSX) and Redmile Group LLC to fund the final stages of development through commercializatio...

2019-06-28 16:00 15000

Saluda Medical Secures Debt Financing From Medtronic

Proceeds to Fund Continued Development of Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System Evoke Trial Validates Level I Evidence Achieved Through First Double-Blind Randomized U.S. Pivotal Study in SCS ARTARMON, Australia, June 27, 2019 /PRNewswire/ -- Saluda Medical Pty...

2019-06-27 16:00 1271

Medical Travel Companions (MTC), the Leading Travel Assistance Provider, Joins the HERE Mobility Marketplace

Partnership to provide B2B ground transportation solutions for customers in need of non-medical travel assistance from transportation hubs across the world SYDNEY, June 27, 2019 /PRNewswire/ -- HERE Mobility , announced today that Medical Travel Companions (MTC), a le...

2019-06-27 11:00 1178

I-Mab Announces Dosing of First Patient in a Phase I Clinical Trial of TJC4, a Potentially Differentiated CD47 Antibody, for the Treatment of Cancers in the United States

GAITHERSBURG, Md., June 25, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces onJune 24, 2019, that the first patient has been dosed in a ...

2019-06-25 22:01 1056

Education Resources, Inc. Unveils New Website And Brand Identity

Improved Website and Updated Brand Logo Highlights Company's Continued Commitment to the Therapy Community BOSTON, June 25, 2019 /PRNewswire/ -- Education Resources, Inc. (ERI), a leading provider of continuing education courses for physical therapists, occupational therapists, and speech-langua...

2019-06-25 06:07 1300

Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Device Companies

SHANGHAI and NEW YORK, June 24, 2019 /PRNewswire/ -- Target Health Inc. and dMed Biopharmaceuticals Company Limited have joined forces to help Western and Chinese biopharma and device companies capitalize on the rapid internationalization of clinical trials between the US andChina while maintain...

2019-06-25 04:00 1077
12345 ... 215